Europe Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Organic Chemicals, Inorganic Chemicals, and Other Products); Functionality (Fillers and Diluents, Suspending and Viscosity Agents, Coating Agents, Binders, Preservatives, Emulsifying Agents, and Other Functionalities); Type of Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Other Formulations)

Code: TIPRE00022813 | Pages: 167 | Industry: Pharmaceuticals | Date: Jun 2021 | Type: Regional

Market Introduction

Without an appropriate delivery system, the best new therapeutic entity in the world is of no benefit. Today, medicines including tablets, capsules, oral liquids, topical creams and gels, transdermal patches, injectable products, implants, eye products, nasal products, inhalers and suppositories, are available in many dosage forms. Pharmaceutical excipients are substances which are used in the form of a pharmaceutical dosage, not for their direct therapeutic action, but for the purpose of aiding the production process, protecting, supporting or enhancing stability, or for bioavailability or acceptability of patients. They also assist in the identification of products and improve the overall safety or function of the product during its storage or use.

Thus, a surge in the generics market are expected to create a significant demand for pharmaceutical excipients in the coming years, which is further anticipated to drive the pharmaceutical excipients market.

Critical drugs can be added to the list in due course as further clinical policies are developed to support the COVID-19 response. Likely, any medicine containing a new active substance for the treatment of viral diseases falls within the mandatory scope of the centralized procedure, meaning that they must be assessed by the European Medicines Agency (EMA) and authorized by the European Commission. EMA is ready to support medicine developers with all available regulatory tools to advance and expedite the development of effective measures to fight and prevent the spread of this virus. These include fast tracked scientific advice, PRIME scheme, accelerated assessments and conditional marketing authorizations. Furthermore, growing research activities to develop treatment against corona virus is likely to favor the growth of the market. As Europe has been impacted by the Covid-19 pandemic, an extensive clinical research is currently being conducted to identify effective therapies. The UK dominates the Covid-19 research space, and accounts for the largest number of clinical trials (24.5%), which is then followed by Spain (13.2%), France (9.5%), Italy (5.3%), Russia (4.8%), and Germany (3.8%).


Get more information on this report :



Market Overview and Dynamics

The pharmaceutical excipients market in Europe is expected to grow from US$ 2,560.5 million in 2019 to US$ 3,796.4 million by 2027; it is estimated to grow at a CAGR of 5.2% from 2020 to 2027. Excipients are an integral component of pharmaceutical products that primarily determine the structure of dosage type and its role in delivering drugs. Excipients significantly affect the process ability, aesthetics, efficiency, and patient compliance with the dosage form. Thus, the use of excipients in a formulation requires an assurance and a clear understanding of their quality, safety, and performance attributes. The principal role of excipients is to support patient acceptability, enhance stability, bioavailability, and assist in the effectiveness. The generics industry has witnessed a remarkable run over the last decade, with companies achieving above-average shareholder returns. Generic drugs are the alternatives to branded drugs with the same dosage form, safety, strength, administration route, and quality. The market consists of revenues made by companies manufacturing pharmaceutical excipients through the sales of these excipients. In addition, many blockbuster drugs are on the brink of losing their patents. The patent cliff has resulted in billions dollars’ worth of brand drug sales losing patent protection. Generic drug companies are free to produce their own replicas when patents expire, which can cost up to 80% less than the originals, eventually resulting in a sharp and sudden loss of profits for the companies that developed them. Use of functionality excipients, allows pharmaceutical firms to extend patents. The need to cut prices, generic competition, and lack of innovation are weighing the pharmaceutical industry down. Excipients have become an integral element in the manufacturing of tablets as these provide improved functionality in pharmaceuticals and aid in drug development and innovation, which, in turn help improve patent life at a lower cost. Excipients play a significant role in helping pharmaceutical manufacturers by increasing treatment effectiveness and compliance. Thus, a surge in generics market is expected to drive the pharmaceutical excipients market.

 

Key Market Segments

In terms of product, the organic chemicals segment accounted for the largest share of the Europe pharmaceutical excipients market in 2019. In terms of functionality, the fillers and diluents segment held a larger market share of the pharmaceutical excipients market in 2019. In terms of type of formulation, the oral formulations segment held a larger market share of the pharmaceutical excipients market in 2019.

 

 

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Pharmaceutical excipients market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are DuPont de Nemours, Inc., Roquette Frères, Ashland Global Holdings, Inc., BASF SE, Evonik Industries AG, Associated British Foods Plc, Archer Daniels Midland Company, Lubrizol Corporation, DFE Pharma, and Croda International Plc.

 

Reasons to buy report

  • To understand the Europe pharmaceutical excipients market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe pharmaceutical excipients market
  • Efficiently plan M&A and partnership deals in Europe pharmaceutical excipients market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe pharmaceutical excipients market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

 

EUROPE PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION

By Product

  • Organic Chemicals
  • Inorganic Chemicals
  • Other Products

By Functionality

  • Fillers & Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Preservatives
  • Emulsifying Agents
  • Other Functionalities

 

By Type of Formulation

  • Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other Formulations

 

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

 

 

Companies Mentioned

  1. DuPont de Nemours, Inc.
  2. Roquette Frères
  3. Ashland Global Holdings, Inc.
  4. BASF SE
  5. Evonik Industries AG
  6. Associated British Foods Plc
  7. Archer Daniels Midland Company
  8. Lubrizol Corporation
  9. Croda International Plc
  10. DFE Pharma
 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Pharmaceutical Excipients Market – By Product

1.3.2          Pharmaceutical Excipients Market – By Functionality

1.3.3          Pharmaceutical Excipients Market – By Type of Formulation

1.3.4          Europe Pharmaceutical Excipients Market – By Country

2.           Europe Pharmaceutical Excipients Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Europe Pharmaceutical Excipients Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Pharmaceutical Excipients Market- Europe PEST Analysis

4.3          Expert Opinion

5.           Europe Pharmaceutical Excipients Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Surge In Generics Market

5.1.2          Growth of the Pharmaceutical Market Backed By Multi-Functional Excipients

5.2          Market Restraints

5.2.1          Cost and Time Intensive Drug Development Process

5.3          Future Trends

5.3.1          Rising Demand and Emphasis on Co-Processed Excipients

5.3.2          Improving Excipient Capabilities due to Nanotechnology

5.4          Impact Analysis

6.           Pharmaceutical Excipients Market – Europe Analysis

6.1          Europe Pharmaceutical Excipients Market Revenue Forecasts and Analysis

7.           Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2027 – By Product

7.1          Overview

7.2          Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)

7.3          Organic Chemicals

7.3.1          Overview

7.3.2          Organic Chemicals: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

7.4          Inorganic Chemicals

7.4.1          Overview

7.4.2          Inorganic Chemicals: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

7.5          Other Products

7.5.1          Overview

7.5.2          Other Products: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.           Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2027 – By Functionality

8.1          Overview

8.2          Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)

8.3          Fillers And Diluents

8.3.1          Overview

8.3.2          Fillers and Diluents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.4          Suspending And Viscosity Agents

8.4.1          Overview

8.4.2          Suspending and Viscosity Agents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.5          Coating Agents

8.5.1          Overview

8.5.2          Coating Agents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.6          Binders

8.6.1          Overview

8.6.2          Binders: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.7          Preservatives

8.7.1          Overview

8.7.2          Preservatives: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.8          Emulsifying Agents

8.8.1          Overview

8.8.2          Emulsifying Agents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

8.9          Other Functionalities

8.9.1          Overview

8.9.2          Other Functionalities: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

9.           Europe Pharmaceutical Excipients Market Analysis and Forecasts to 2027– By Type of Formulation

9.1          Overview

9.2          Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)

9.3          Oral Formulations

9.3.1          Overview

9.3.2          Oral Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

9.4          Topical Formulations

9.4.1          Overview

9.4.2          Topical Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

9.5          Parenteral Formulations

9.5.1          Overview

9.5.2          Parenteral Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

9.6          Other Formulations

9.6.1          Overview

9.6.2          Other Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

10.        Pharmaceutical Excipients Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1        Europe: Pharmaceutical Excipients Market

10.1.1        Overview

10.1.2        Europe: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)

10.1.3        Germany: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1          Germany: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2          Germany: Pharmaceutical Excipients Market, by Product, 2018–2027 (USD Million)

10.1.3.3          Germany: Pharmaceutical Excipients Market, by Functionality, 2018–2027 (USD Million)

10.1.3.4          Germany: Pharmaceutical Excipients Market, by Type of Formulation, 2018–2027 (USD million)

10.1.4        UK: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1          UK Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2          UK: Pharmaceutical Excipients Market, by Product, 2018–2027 (USD Million)

10.1.4.3          UK: Pharmaceutical Excipients Market, by Functionality, 2018–2027 (USD Million)

10.1.4.4          UK: Pharmaceutical Excipients Market, by Type of Formulation, 2018–2027 (USD million)

10.1.5        France: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1          France: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2          France: Pharmaceutical Excipients Market, by Product, 2018–2027 (USD Million)

10.1.5.3          France: Pharmaceutical Excipients Market, by Functionality, 2018–2027 (USD Million)

10.1.5.4          France: Pharmaceutical Excipients Market, by Type of Formulation, 2018–2027 (USD million)

10.1.6        Spain: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1          Spain: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2          Spain: Pharmaceutical Excipients Market, by Product, 2018–2027 (USD Million)

10.1.6.3          Spain: Pharmaceutical Excipients Market, by Functionality, 2018–2027 (USD Million)

10.1.6.4          Spain: Pharmaceutical Excipients Market, by Type of Formulation, 2018–2027 (USD million)

10.1.7        Italy: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1          Italy: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2          Italy: Pharmaceutical Excipients Market, by Product, 2018–2027 (USD Million)

10.1.7.3          Italy: Pharmaceutical Excipients Market, by Functionality, 2018–2027 (USD Million)

10.1.7.4          Italy: Pharmaceutical Excipients Market, by Type of Formulation, 2018–2027 (USD million)

11.        Impact Of COVID-19 Pandemic on Europe Pharmaceutical Excipients Market

11.1        Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.3        Organic Developments

12.3.1        Overview

12.4        Inorganic Developments

12.4.1        Overview

13.        COMPANY PROFILES

13.1        DuPont de Nemours, Inc.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Roquette Frères

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        Ashland Global Holdings Inc.

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        BASF SE

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Evonik

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Associated British Foods plc

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Archer Daniels Midland Company

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Lubrizol Corporation

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

13.9        DFE Pharma

13.9.1        Key Facts

13.9.2        Business Description

13.9.3        Products and Services

13.9.4        Financial Overview

13.9.5        SWOT Analysis

13.9.6        Key Developments

13.10     Croda International plc

13.10.1      Key Facts

13.10.2      Business Description

13.10.3      Products and Services

13.10.4      Financial Overview

13.10.5      SWOT Analysis

13.10.6      Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

 

LIST OF TABLES

Table 1.              Germany Pharmaceutical Excipients Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.              Germany Pharmaceutical Excipients Market, by Functionality – Revenue and Forecast to 2027 (USD Million)

Table 3.              Germany Pharmaceutical Excipients Market, by Type of Formulation – Revenue and Forecast to 2027 (USD Million)

Table 4.              UK Pharmaceutical Excipients Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.              UK Pharmaceutical Excipients Market, by Functionality – Revenue and Forecast to 2027 (USD Million)

Table 6.              UK Pharmaceutical Excipients Market, by Type of Formulation – Revenue and Forecast to 2027 (USD Million)

Table 7.              France Pharmaceutical Excipients Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.              France Pharmaceutical Excipients Market, by Functionality – Revenue and Forecast to 2027 (USD Million)

Table 9.              France Pharmaceutical Excipients Market, by Type of Formulation – Revenue and Forecast to 2027  (USD Million)

Table 10.            Spain Pharmaceutical Excipients Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.            Spain Pharmaceutical Excipients Market, by Functionality – Revenue and Forecast to 2027 (USD Million)

Table 12.            Spain Pharmaceutical Excipients Market, by Type of Formulation – Revenue and Forecast to 2027 (USD Million)

Table 13.            Italy Pharmaceutical Excipients Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.            Italy Pharmaceutical Excipients Market, by Functionality – Revenue and Forecast to 2027 (USD Million)

Table 15.            Italy Pharmaceutical Excipients Market, by Type of Formulation – Revenue and Forecast to 2027 (USD Million)

Table 16.            Organic Developments Done By Companies

Table 17.            Inorganic Developments Done By Companies

Table 18.            Glossary of Terms, Pharmaceutical Excipients Market

LIST OF FIGURES

Figure 1.            Pharmaceutical Excipients Market Segmentation

Figure 2.            Europe Pharmaceutical Excipients Market Overview

Figure 3.            Organic Chemicals Segment Held Largest Share of Product in Pharmaceutical Excipients Market

Figure 4.            Oral Formulations Segment Held Largest Share of Type of Formulation in Pharmaceutical Excipients Market

Figure 5.            UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            Pharmaceutical Excipients Market - Europe PEST Analysis

Figure 7.            Pharmaceutical Excipients Market Impact Analysis of Driver and Restraints

Figure 8.            Europe Pharmaceutical Excipients Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.            Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)

Figure 10.          Organic Chemicals: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 11.          Inorganic Chemicals: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 12.          Other Products: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 13.          Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)

Figure 14.          Fillers and Diluents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 15.          Suspending and Viscosity Agents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 16.          Coating Agents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 17.          Binders: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 18.          Preservatives: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 19.          Emulsifying Agents: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 20.          Other Functionalities: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 21.          Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)

Figure 22.          Oral Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 23.          Topical Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 24.          Parenteral Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 25.          Other Formulations: Pharmaceutical Excipients Market– Revenue and Forecast to 2027 (USD Million)

Figure 26.          Europe: Pharmaceutical Excipients Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.          Europe: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)

Figure 28.          Germany: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.          UK: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.          France: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.          Spain: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.          Italy: Pharmaceutical Excipients Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.          Impact of COVID-19 Pandemic in European Country Markets

Figure 34.          Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. DuPont de Nemours, Inc.
  2. Roquette Frères
  3. Ashland Global Holdings, Inc.
  4. BASF SE
  5. Evonik Industries AG
  6. Associated British Foods Plc
  7. Archer Daniels Midland Company
  8. Lubrizol Corporation
  9. Croda International Plc
  10. DFE Pharma

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000